Skip to main content
Premium Trial:

Request an Annual Quote

As Third Wave Stock Continues Sliding, Director Buys 3,500 Shares

NEW YORK, March 3 (GenomeWeb News) - Third Wave Technologies Director Brunner Gordon yesterday bought 3,500 shares in his company, as the stock continued to slide for the seventh consecutive day since Third Wave reported  lackluster fourth-quarter earnings on Feb. 23.

 

Third Wave's stock was down 7.35 percent, or $.44, at $5.55 in mid-afternoon trading today. The stock has shed 27 percent of its value since the fourth-quarter earnings were reported on Feb. 23. The shares last traded at this level in early September.

 

Investors continued dumping the stock after two investment banks -- one on  Feb. 23 and another on  March 1 -- downgraded their ratings of Third Wave.

 

Gordon bought the stock as the share price reached $6.22, and he now owns a total of 39,500 shares in the company, according to Insidercow.com, a web site that follows insider transactions.

 

As GenomeWeb News  reported on Feb. 23, Third Wave said total revenues for the three-month period ended Dec. 31, 2004, fell 16.5 percent, while net losses tripled.

 

Total receipts for the three-month period ended Dec. 31, 2004, fell to $8.1 million from $9.7 million during the same quarter in 2003. Third Wave said that more than half, or $4.7 million, of total revenues were derived from clinical molecular diagnostics, meaning that this business segment grew almost 90 percent compared to the fourth quarter of 2003.

The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.